Harrow, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Harrow, Inc. (HROW) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 1.73 million shares for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2025-11-10
- Harrow, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 1.73M shares.
- Harrow, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 2.06M shares.
- Harrow, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2019-03-31 was 5.84M shares, a 42.23% decline year-over-year.
- Harrow, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2018-06-30 was 23.18M shares, a 0.01% decline year-over-year.
- Harrow, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2018 was 22.54M shares, a 12.54% increase from fiscal 2017.
- Harrow, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2017 was 20.03M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|
| 2025-09-30 | 1.73M shares 10-Q · filed 2025-11-10 | ||||
| 2025-06-30 | 2.06M shares 10-Q · filed 2025-08-11 | ||||
| 2019-09-30 | 5.26M shares 10-Q · filed 2019-11-13 | ||||
| 2019-06-30 | 5.33M shares 10-Q · filed 2019-08-14 | ||||
| 2019-03-31 | 5.84M shares 10-Q · filed 2019-05-09 | ||||
| 2018-12-31 | 22.54M shares 10-K · filed 2019-03-12 | ||||
| 2018-09-30 | 8.39M shares 10-Q · filed 2019-11-13 | ||||
| 2018-06-30 | 23.18M shares 10-Q · filed 2018-08-06 | 10.25M shares 10-Q · filed 2019-08-14 | 21.07M shares 10-Q · filed 2018-08-06 | ||
| 2018-03-31 | 10.11M shares 10-Q · filed 2019-05-09 | ||||
| 2017-12-31 | 20.03M shares 10-K · filed 2019-03-12 | ||||
| 2017-06-30 | 23.18M shares 10-Q · filed 2018-08-06 | 19.57M shares 10-Q · filed 2018-08-06 | 2.97M shares 10-Q · filed 2017-08-10 | ||
| 2015-09-30 | 382.51K shares 10-Q · filed 2015-11-12 | ||||
| 2015-06-30 | 3.01M shares 10-Q · filed 2015-08-12 | ||||
| 2015-03-31 | 3.34M shares 10-Q · filed 2015-05-13 | ||||
| 2014-09-30 | 3.05M shares 10-Q · filed 2015-11-12 | ||||
| 2014-06-30 | 3.42M shares 10-Q · filed 2015-08-12 | ||||
| 2014-03-31 | 3.38M shares 10-Q · filed 2015-05-13 | ||||
| 2013-06-30 | 3.14M shares 10-Q · filed 2013-08-14 | ||||
| 2012-09-30 | 8.35M shares 10-Q · filed 2012-11-14 | ||||
| 2012-06-30 | 1.48M shares 10-Q · filed 2013-08-14 | ||||
| 2011-09-30 | 395.85K shares 10-Q · filed 2012-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |